{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:37:13Z","timestamp":1766853433715,"version":"3.48.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Mersin University Scientific Research Projects","award":["[2021-1-TP2-4131]"],"award-info":[{"award-number":["[2021-1-TP2-4131]"]}]},{"name":"Mersin University Scientific Research Projects","award":["[2021-1-TP2-4131]"],"award-info":[{"award-number":["[2021-1-TP2-4131]"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10244-5","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T01:16:38Z","timestamp":1737162998000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circulating chemokine levels and receptor polymorphisms have potential as biomarkers for fibrosis stages in patients with chronic hepatitis C infection"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9090-8180","authenticated-orcid":false,"given":"Seren O\u011fultekin","family":"Teneke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5113-5509","authenticated-orcid":false,"given":"Mehmet Sami","family":"Serin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1542-0556","authenticated-orcid":false,"given":"Zehra","family":"\u00d6ks\u00fcz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2835-6979","authenticated-orcid":false,"given":"G\u00fclhan Orekici","family":"Temel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1404-7515","authenticated-orcid":false,"given":"Serkan","family":"Yara\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2935-5580","authenticated-orcid":false,"given":"Enver","family":"\u00dc\u00e7bilek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6704-4716","authenticated-orcid":false,"given":"Orhan","family":"Sezgin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,18]]},"reference":[{"key":"10244_CR1","unstructured":"WHO, Hepatitis C https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c#:~:text=Globally%2\u00a0C%20an%20estimated%2058%20million,with%20chronic%20hepatitis%20\u00a0C%20infection"},{"issue":"7","key":"10244_CR2","doi-asserted-by":"publisher","first-page":"102443","DOI":"10.1016\/j.jiph.2024.04.027","volume":"17","author":"TY - Ou","year":"2024","unstructured":"Ou TY, Huy LD, Mayne J et al (2024) Global mortality of chronic liver diseases attributable to Hepatitis B virus and Hepatitis C virus infections from 1990 to 2019 and projections to 2030. J Infect Public Health 17(7):102443. https:\/\/doi.org\/10.1016\/j.jiph.2024.04.027","journal-title":"J Infect Public Health"},{"issue":"10407","key":"10244_CR3","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(23)01320-X","volume":"402","author":"M - Martinello","year":"2023","unstructured":"Martinello M, Solomon SS, Terrault NA, Dore GJ, Lancet, London (2023) England), 402(10407), 1085\u20131096. https:\/\/doi.org\/10.1016\/S0140-6736(23)01320-X","journal-title":"England)"},{"key":"10244_CR4","doi-asserted-by":"publisher","unstructured":"Khatun M, Ray RB (2019) Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis. Cells. 8(10):1249. Published 2019 Oct 14. https:\/\/doi.org\/10.3390\/cells8101249","DOI":"10.3390\/cells8101249"},{"issue":"5","key":"10244_CR5","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1177\/2050640619840149","volume":"7","author":"S - Ekpanyapong","year":"2019","unstructured":"Ekpanyapong S, Reddy KR (2019) Hepatitis C virus therapy in advanced liver disease: outcomes and challenges. United Eur Gastroenterol J 7(5):642\u2013650. https:\/\/doi.org\/10.1177\/2050640619840149","journal-title":"United Eur Gastroenterol J"},{"issue":"8","key":"10244_CR6","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1093\/infdis\/jiw332","volume":"214","author":"M - Zeremski","year":"2016","unstructured":"Zeremski M, Dimova RB, Pillardy J, de Jong YP, Jacobson IM, Talal AH (2016) Fibrosis progression in patients with chronic Hepatitis C virus infection. J Infect Dis 214(8):1164\u20131170. https:\/\/doi.org\/10.1093\/infdis\/jiw332","journal-title":"J Infect Dis"},{"issue":"1","key":"10244_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1055\/s-2000-9258","volume":"20","author":"T - Poynard","year":"2000","unstructured":"Poynard T, Ratziu V, Benmanov Y, Di Martino V, Bedossa P, Opolon P (2000) Fibrosis in patients with chronic hepatitis C: detection and significance. Semin Liver Dis 20(1):47\u201355. https:\/\/doi.org\/10.1055\/s-2000-9258","journal-title":"Semin Liver Dis"},{"issue":"47","key":"10244_CR8","doi-asserted-by":"publisher","first-page":"7149","DOI":"10.3748\/wjg.14.7149","volume":"14","author":"JR - Larrubia","year":"2008","unstructured":"Larrubia JR, Benito-Mart\u00ednez S, Calvino M, Sanz-de-Villalobos E, Parra-Cid T (2008) Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection. World J Gastroenterol 14(47):7149\u20137159. https:\/\/doi.org\/10.3748\/wjg.14.7149","journal-title":"World J Gastroenterol"},{"key":"10244_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","volume":"63","author":"R -Tokunaga","year":"2018","unstructured":"Tokunaga R, Zhang W, Naseem M et al (2018) CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - A target for novel cancer therapy. Cancer Treat Rev 63:40\u201347. https:\/\/doi.org\/10.1016\/j.ctrv.2017.11.007","journal-title":"Cancer Treat Rev"},{"issue":"7481","key":"10244_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature12681","volume":"505","author":"BS -Ding","year":"2014","unstructured":"Ding BS, Cao Z, Lis R et al (2014) Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis. Nature 505(7481):97\u2013102. https:\/\/doi.org\/10.1038\/nature12681","journal-title":"Nature"},{"issue":"1","key":"10244_CR11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/hep.27798","volume":"62","author":"O -Garc\u00eda-Irigoyen","year":"2015","unstructured":"Garc\u00eda-Irigoyen O, Latasa MU, Carotti S et al (2015) Matrix metalloproteinase 10 contributes to hepatocarcinogenesis in a novel crosstalk with the stromal derived factor 1\/C-X-C chemokine receptor 4 axis. Hepatology 62(1):166\u2013178. https:\/\/doi.org\/10.1002\/hep.27798","journal-title":"Hepatology"},{"issue":"2","key":"10244_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.15403\/jgld-4660","volume":"32","author":"H - Li","year":"2023","unstructured":"Li H (2023) Update on the role of chemokines and Chemokine receptors in Liver Fibrosis. J Gastrointest Liver Diseases: JGLD 32(2):241\u2013256. https:\/\/doi.org\/10.15403\/jgld-4660","journal-title":"J Gastrointest Liver Diseases: JGLD"},{"issue":"10","key":"10244_CR13","doi-asserted-by":"publisher","first-page":"5226","DOI":"10.4049\/jimmunol.1202909","volume":"190","author":"A - Wehr","year":"2013","unstructured":"Wehr A, Baeck C, Heymann F et al (2013) Chemokine receptor CXCR6-dependent hepatic NK T cell accumulation promotes inflammation and liver fibrosis. J Immunol 190(10):5226\u20135236. https:\/\/doi.org\/10.4049\/jimmunol.1202909","journal-title":"J Immunol"},{"issue":"3","key":"10244_CR14","doi-asserted-by":"publisher","first-page":"ftab007","DOI":"10.1093\/femspd\/ftab007","volume":"79","author":"MC -Magri","year":"2021","unstructured":"Magri MC, Alvarez MSM, Iogi AA et al (2021) Study of CXCL9-11 gene polymorphisms in liver fibrosis among patients with chronic hepatitis C. Pathog Dis 79(3):ftab007. https:\/\/doi.org\/10.1093\/femspd\/ftab007","journal-title":"Pathog Dis"},{"issue":"13","key":"10244_CR15","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.2217\/fon-2017-0613","volume":"4","author":"LF -Qin","year":"2018","unstructured":"Qin LF, Qin JM, Zhang JQ, Lv XP, Huang LY, Wang JJ (2018) CXCL12 and CXCR4 polymorphisms and expressions in peripheral blood from patients of hepatocellular carcinoma. Future Oncol 4(13):1261\u20131271. https:\/\/doi.org\/10.2217\/fon-2017-0613","journal-title":"Future Oncol"},{"key":"10244_CR16","doi-asserted-by":"publisher","unstructured":"Ajmera V, Huang H, Dao D et al (2019) Host genetic variant in CXCL16 may be Associated with Hepatitis B Virus-related Acute Liver failure. Cell Mol Gastroenterol Hepatol 2477\u2013479e4. https:\/\/doi.org\/10.1016\/j.jcmgh.2018.09.018","DOI":"10.1016\/j.jcmgh.2018.09.018"},{"key":"10244_CR17","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.5336\/medsci.2009-13508","volume":"30","author":"O - Sezgin","year":"2010","unstructured":"Sezgin O, Alt\u0131nta\u015f E, \u00dc\u00e7bilek E, Tombak A (2010) Percutaneous liver biopsies: safety and efcacy. Turkiye Klinikleri J Med Sci 30:1287\u20132129. https:\/\/doi.org\/10.5336\/medsci.2009-13508","journal-title":"Turkiye Klinikleri J Med Sci"},{"issue":"6","key":"10244_CR18","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K - Ishak","year":"1995","unstructured":"Ishak K, Baptista A, Bianchi L et al (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22(6):696\u2013699. https:\/\/doi.org\/10.1016\/0168-8278(95)80226-6","journal-title":"J Hepatol"},{"issue":"5","key":"10244_CR19","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/hep.1840010511","volume":"1","author":"RG - Knodell","year":"1981","unstructured":"Knodell RG, Ishak KG, Black WC et al (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1(5):431\u2013435. https:\/\/doi.org\/10.1002\/hep.1840010511","journal-title":"Hepatology"},{"key":"10244_CR20","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1055\/s-0043-103952","volume":"38","author":"CF - Dietrich","year":"2017","unstructured":"Dietrich CF, Bamber J, Berzigotti A et al (2017) EFSUMB Guidelinesand recommendations on the clinical use of Liver Ultrasound Elastography, Update 2017 (LongVersion). Ultraschall Med 38:e48\u2013e20. https:\/\/doi.org\/10.1055\/s-0043-103952","journal-title":"Ultraschall Med"},{"key":"10244_CR21","doi-asserted-by":"publisher","unstructured":"Ferrari SM, Fallahi P, Ruffilli I et al (2019) Immunomodulation of CXCL10 Secretion by Hepatitis C Virus: Could CXCL10 Be a Prognostic Marker of Chronic Hepatitis C? J Immunol Res. 2019:5878960. Published 2019 Aug 8. https:\/\/doi.org\/10.1155\/2019\/5878960","DOI":"10.1155\/2019\/5878960"},{"issue":"16","key":"10244_CR22","doi-asserted-by":"publisher","first-page":"8846","DOI":"10.3390\/ijms23168846","volume":"23","author":"M - Zajkowska","year":"2022","unstructured":"Zajkowska M, Mroczko B (2022) Chemokines in Primary Liver Cancer. Int J Mol Sci 23(16):8846. https:\/\/doi.org\/10.3390\/ijms23168846","journal-title":"Int J Mol Sci"},{"key":"10244_CR23","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.cyto.2018.05.029","volume":"111","author":"A - Chalin","year":"2018","unstructured":"Chalin A, Lefevre B, Devisme C et al (2018) Serum CXCL10, CXCL11, CXCL12, and CXCL14 chemokine patterns in patients with acute liver injury. Cytokine 111:500\u2013504. https:\/\/doi.org\/10.1016\/j.cyto.2018.05.029","journal-title":"Cytokine"},{"key":"10244_CR24","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cyto.2019.02.006","volume":"117","author":"A - Chalin","year":"2019","unstructured":"Chalin A, Lefevre B, Devisme C, Barget N, Amiot L, Samson M (2019) Circulating levels of CXCL11 and CXCL12 are biomarkers of cirrhosis in patients with chronic hepatitis C infection. Cytokine 117:72\u201378. https:\/\/doi.org\/10.1016\/j.cyto.2019.02.006","journal-title":"Cytokine"},{"issue":"2","key":"10244_CR25","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1128\/JVI.01388-08","volume":"83","author":"KJ - Helbig","year":"2009","unstructured":"Helbig KJ, Ruszkiewicz A, Lanford RE et al (2009) Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro. J Virol 83(2):836\u2013846. https:\/\/doi.org\/10.1128\/JVI.01388-08","journal-title":"J Virol"},{"issue":"6","key":"10244_CR26","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3349\/ymj.2011.52.6.871","volume":"52","author":"W - Kang","year":"2011","unstructured":"Kang W, Shin EC (2011) Clinical implications of chemokines in acute and chronic hepatitis C virus infection. Yonsei Med J 52(6):871\u2013878. https:\/\/doi.org\/10.3349\/ymj.2011.52.6.871","journal-title":"Yonsei Med J"},{"issue":"2","key":"10244_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1684\/ecn.2010.0192","volume":"21","author":"F - Capone","year":"2010","unstructured":"Capone F, Costantini S, Guerriero E et al (2010) Serum cytokine levels in patients with hepatocellular carcinoma. Eur Cytokine Netw 21(2):99\u2013104. https:\/\/doi.org\/10.1684\/ecn.2010.0192","journal-title":"Eur Cytokine Netw"},{"key":"10244_CR28","doi-asserted-by":"publisher","unstructured":"Kryczek I, Wei S, Keller E, Liu R, Zou W (2007) Stroma-derived factor (SDF-1\/CXCL12) and human tumor pathogenesis. Am J Physiol Cell Physiol. 2007;292(3):C987-C995. https:\/\/doi.org\/10.1152\/ajpcell.00406.2006","DOI":"10.1152\/ajpcell.00406.2006"},{"issue":"2","key":"10244_CR29","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","volume":"128","author":"L - Cast\u00e9ra","year":"2005","unstructured":"Cast\u00e9ra L, Vergniol J, Foucher J et al (2005) Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128(2):343\u2013350. https:\/\/doi.org\/10.1053\/j.gastro.2004.11.018","journal-title":"Gastroenterology"},{"issue":"11","key":"10244_CR30","doi-asserted-by":"publisher","first-page":"807","DOI":"10.7326\/0003-4819-158-11-201306040-00005","volume":"158","author":"R - Chou","year":"2013","unstructured":"Chou R, Wasson N (2013) Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review. Ann Intern Med 158(11):807\u2013820. https:\/\/doi.org\/10.7326\/0003-4819-158-11-201306040-00005","journal-title":"Ann Intern Med"},{"issue":"10","key":"10244_CR31","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1111\/jvh.13570","volume":"28","author":"S - Varchetta","year":"2021","unstructured":"Varchetta S, Mele D, D\u2019Ambrosio R et al (2021) A new algorithm shows superior ability to discriminate liver fibrosis stages in chronic hepatitis C. J Viral Hepat 28(10):1443\u20131451. https:\/\/doi.org\/10.1111\/jvh.13570","journal-title":"J Viral Hepat"},{"issue":"6","key":"10244_CR32","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/j.1478-3231.2011.02504.x","volume":"31","author":"F - Tacke","year":"2011","unstructured":"Tacke F, Zimmermann HW, Berres ML, Trautwein C, Wasmuth HE (2011) Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases. Liver Int 31(6):840\u2013849. https:\/\/doi.org\/10.1111\/j.1478-3231.2011.02504.x","journal-title":"Liver Int"},{"issue":"8","key":"10244_CR33","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s10067-013-2246-y","volume":"32","author":"A - Antonelli","year":"2013","unstructured":"Antonelli A, Fallahi P, Ferrari SM et al (2013) Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2. Clin Rheumatol 32(8):1147\u20131154. https:\/\/doi.org\/10.1007\/s10067-013-2246-y","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10244_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/039463201302600105","volume":"26","author":"A - Antonelli","year":"2013","unstructured":"Antonelli A, Fallahi P, Ferrari SM et al (2013) High circulating chemokines (C-X-C motif) ligand 9, and (C-X-C motif) ligand 11, in hepatitis C-associated cryoglobulinemia. Int J Immunopathol Pharmacol 26(1):49\u201357. https:\/\/doi.org\/10.1177\/039463201302600105","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1","key":"10244_CR35","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40169-017-0156-3","volume":"6","author":"M\u00c1 - Jim\u00e9nez-Sousa","year":"2017","unstructured":"Jim\u00e9nez-Sousa M\u00c1, G\u00f3mez-Moreno AZ, Pineda-Tenor D et al (2017) CXCL9-11 polymorphisms are associated with liver fibrosis in patients with chronic hepatitis C: a cross-sectional study. Clin Transl Med 6(1):26. https:\/\/doi.org\/10.1186\/s40169-017-0156-3","journal-title":"Clin Transl Med"},{"issue":"6","key":"10244_CR36","first-page":"1290","volume":"21","author":"Y - Lu","year":"2017","unstructured":"Lu Y, Lin LY, Tan JG et al (2017) A correlation study between gene polymorphism of Th cell expressed chemokine receptor CXCR3 and its ligand levels with HCV infection prognosis. Eur Rev Med Pharmacol Sci 21(6):1290\u20131295","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"13","key":"10244_CR37","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.2217\/fon-2017-0613","volume":"14","author":"LF - Qin","year":"2018","unstructured":"Qin LF, Qin JM, Zhang JQ, Lv XP, Huang LY, Wang JJ (2018) CXCL12 and CXCR4 polymorphisms and expressions in peripheral blood from patients of hepatocellular carcinoma. Future Oncol 14(13):1261\u20131271. https:\/\/doi.org\/10.2217\/fon-2017-0613","journal-title":"Future Oncol"},{"issue":"4","key":"10244_CR38","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1515\/CCLM.2009.092","volume":"47","author":"CC -Chang","year":"2009","unstructured":"Chang CC, Chen SC, Hsieh YH et al (2009) Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma. Clin Chem Lab Med 47(4):412\u2013418. https:\/\/doi.org\/10.1515\/CCLM.2009.092","journal-title":"Clin Chem Lab Med"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10244-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10244-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10244-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:33:26Z","timestamp":1766853206000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10244-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,18]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10244"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10244-5","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2025,1,18]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The whole study was conducted according to the Declaration of Helsinki and approved by the Ethical Committee of Mersin University Clinical Research (approval number 2017\/88).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors have read and give the Journal permission to publish the version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"138"}}